Overview
Status
Active
Registry date
2001-11-10
Share capital
476 835,00 PLN
Registered address
al. Aleje Jerozolimskie 142B, 02-305 Warszawa, Poland
Electronic delivery address
AE:PL-35224-78155-JAITB-13
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 30.88mMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD -10.76mMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 29.31mMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 41.60mMedianUSD 539.29kAverageUSD 10.66m
Industry
Bank accounts
Registered as a VAT taxpayer on 2001-12-17. Active
53 1600 1127 1846 7484 3000 0001- 26 1600 1127 1846 7484 3000 0002
- 69 1600 1127 1846 7484 3000 0004
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Anne Helene Martinet Durocher — Management Board Member
Antoine Bon — Management Board Member
Briac Le Lous — Management Board Member
Nathalie Chauvy — Management Board Member
Ewa Maria Roziel — Management Board Member
Manner of representation
The company is represented by one member of the management board acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Belhyperion Nv | 230 | $77,350.08 | 60.0522% |
Laboratoires Urgo Healthcare | 153 | $51,454.62 | 39.9478% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Briac Michael Le Lous (49)  | Osoba fizyczna sprawująca pośrednią kontrolę nad urgo spółka z ograniczoną odpowiedzialnością jako właściciel udziałów w spółkach grupy urgo - łącznie 32,98% | |
Guirec Le Lous (38) | Osoba fizyczna sprawująca pośrednią kontrolę nad urgo spółka z ograniczoną odpowiedzialnością jako właściciel udziałów w spółkach grupy urgo - łącznie 32,98% | |
Tristan Yann Christophe Le Lous (47) | Osoba fizyczna sprawująca pośrednią kontrolę nad urgo spółka z ograniczoną odpowiedzialnością jako właściciel udziałów w spółkach grupy urgo - łącznie 32,98% |
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
MybestpharmS.A. | 67,531.06 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ITPS.A. | $55,285,362.18 | itpsa.pl | ||
| Orkla CareS.A. | $43,777,691.06 | orklacare.com.pl | ||
| Idalia Ludwikowscysp. j. | $41,868,843.38 | idalia.com.pl | ||
| APS Marcin WalasekS.K.A. | $37,508,581.19 | dentaltree.pl | ||
| DiagnosisS.A. | $37,413,735.72 | diagnosis.pl | ||
| Dermaticsp. z o.o. | $33,423,317.64 | dermatic.pl | ||
| Centrum Zaopatrzenia Medycznego Cezal - WrocławS.A. | $25,656,815.87 | cezal.com.pl | ||
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Ivoclar-Vivadent Polskasp. z o.o. | $17,154,419.26 | ivoclar.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-22 | Share capital change (190,485.00 PLN → 476,835.00 PLN) | |
| 2022-09-23 | Name change (Laboratoria Polfa Łódź → Urgo) | |
| 2018-02-05 | Share capital change (189,240.00 PLN → 190,485.00 PLN) | |
| 2017-11-27 | Address change (Trakt Lubelski 135, 04-790, Warszawa → Al. Aleje Jerozolimskie 142b, 02-305, Warszawa) | |
| 2017-11-27 | Name change (Bio-Profil Polska → Laboratoria Polfa Łódź) |
FAQ
Last updated: 2026-10-02